Schrodinger Inc
NASDAQ:SDGR

Watchlist Manager
Schrodinger Inc Logo
Schrodinger Inc
NASDAQ:SDGR
Watchlist
Price: 20.84 USD 2.32% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Schrodinger Inc?
Write Note

Operating Margin
Schrodinger Inc

-112.9%
Current
-88%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-112.9%
=
Operating Profit
-218.2m
/
Revenue
193.3m

Operating Margin Across Competitors

Country US
Market Cap 1.5B USD
Operating Margin
-113%
Country US
Market Cap 35B USD
Operating Margin
23%
Country US
Market Cap 31.3B USD
Operating Margin
13%
Country AU
Market Cap 23.2B AUD
Operating Margin
71%
Country US
Market Cap 9B USD
Operating Margin
39%
Country JP
Market Cap 967.6B JPY
Operating Margin
23%
Country US
Market Cap 5.7B USD
Operating Margin
2%
Country US
Market Cap 5.4B USD
Operating Margin
12%
Country SE
Market Cap 53.1B SEK
Operating Margin
-41%
Country US
Market Cap 2.4B EUR
Operating Margin
0%
Country CN
Market Cap 16.4B CNY
Operating Margin
16%
No Stocks Found

Schrodinger Inc
Glance View

Market Cap
1.5B USD
Industry
Health Care

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 664 full-time employees. The company went IPO on 2020-02-06. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Company’s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. The Company’s physics-based software platform enables discovery of molecules for drug development and materials applications. Its software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories. The Company’s pipeline includes CDC7, Wee1, MALT1, HIF-2 alpha and SOS1/KRAS. Its CDC7 is a small molecule inhibitor for treatment of solid and liquid tumors.

SDGR Intrinsic Value
14.65 USD
Overvaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-112.9%
=
Operating Profit
-218.2m
/
Revenue
193.3m
What is the Operating Margin of Schrodinger Inc?

Based on Schrodinger Inc's most recent financial statements, the company has Operating Margin of -112.9%.